7 results · 6ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Animas Vibe Insulin Infusion Pump. This product is indicated for continuous subcutaneous infusion of insulin for the treatment of diabetes and has a continuous glucose monitoring feature.

FDA Enforcement
Class II ·Terminated·Animas Corporation·November 5, 2014

JUDKINS PACK

FDA Enforcement
Class II ·Terminated·Cardinal Health 200, LLC·March 24, 2021

Terumo Advanced Perfusion System 1 Ultrasonic Air Sensor 1/4x1/16 UAS BLK, Catalog Number 5785 - Product Usage: intended for use with Terumo and Sarns brand air detection and heart-lung systems to detect gross air bubbles in the line during extracorporeal procedures.

FDA Enforcement
Class II ·Terminated·Terumo Cardiovascular Systems Corporation·September 23, 2020

BRASSELER KM166-310-35 Twist Drill Quick Connect Diameter 3.5 mm, Total Length 112mm, Effective Length, 86mm - Product Usage: Twist drill intended use: to drill into bone in hip or knee surgeries.

FDA Enforcement
Class II ·Terminated·Brasseler USA I Lp·December 11, 2019

Brasseler USA KM169-39-76 Steinmann Pin Single Diamond Smooth, Diameter 2.8 mm, Length 228 mm Product Usage: A Steinmann Pin is used for internal fixation of large bone fractures.

FDA Enforcement
Class II ·Terminated·Brasseler USA I Lp·February 5, 2020

ENROUTE Transcarotid Stent System REF SR-XXYY-CS

FDA Enforcement
Class II ·Terminated·Silk Road Medical Inc·March 3, 2021

Dexcom Receiver, REF: MT22719, (Black, Pin, Blue), Rx Only, containing software version SW10617 and revision 4.0.1.048 - Product Usage: A non-adjunctive invasive glucose sensor is intended to determine glucose levels, and the direction and rate of change of glucose levels in people with diabetes. The device is indicated to replace information obtained from standard blood glucose monitoring devices to make diabetes-related treatment decisions. The device also provides historical glucose information, facilitating long-term therapy adjustments.

FDA Enforcement
Class II ·Terminated·Dexcom Inc·February 12, 2020